Genome Medical attracts $23 mln Series B
South San Francisco-based Genome Medical, a telegenomics company, has raised $23 million in Series B funding. Echo Health Ventures led the round.
11 June 2019•1 min read
South San Francisco-based Genome Medical, a telegenomics company, has raised $23 million in Series B funding. Echo Health Ventures led the round.
